SAN ANTONIO, July 27, 2023 /PRNewswire/ — Fina Biosolutions has selected Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), for the production of an E.coli-expressed CRM197 conjugate vaccine carrier protein. The partnership includes…
Month: July 2023
Duopharma Biotech is the first pharmaceutical company to offer biosimilar products in the Malaysian market. SAN ANTONIO, July 27, 2023 /PRNewswire/ — Frost & Sullivan recently researched the Malaysian biosimilars industry and, based on its findings, recognizes Duopharma Biotech Berhad…
– AIM Is First Japanese Company to Establish Joint Research Agreement in Field of Endoscopic AI – TOKYO, July 27, 2023 /PRNewswire/ — AI Medical Service Inc. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research…
The first-of-its-kind assembly in Africa will take place in Rwanda WATERLOO, Ontario, July 27, 2023 /PRNewswire/ — BlackBerry Limited (NYSE: BB; TSX: BB) announced today that it will participate in Cybertech Africa, in Rwanda. The first-of-its kind event in the region will convene…
SLOUGH, United Kingdom, and RICHMOND, Va., July 27, 2023 /PRNewswire/ — Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending June 30, 2023. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings…
SLOUGH, United Kingdom, and RICHMOND, Va., July 27, 2023 /PRNewswire/ — Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending June 30, 2023. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings…
HEIDELBERG, Germany, July 27, 2023 /PRNewswire/ — NEC Laboratories Europe and NEC Laboratories America have developed a new artificial intelligence (AI) model called Attentive Variational Information Bottleneck (AVIB), which advances the development of therapeutic cancer vaccines. AVIB…
HEIDELBERG, Germany, July 27, 2023 /PRNewswire/ — NEC Laboratories Europe and NEC Laboratories America have developed a new artificial intelligence (AI) model called Attentive Variational Information Bottleneck (AVIB), which advances the development of therapeutic cancer vaccines. AVIB…
HEIDELBERG, Deutschland, 27. Juli 2023 /PRNewswire/ — NEC Laboratories Europe und NEC Laboratories America haben ein neues KI-Modell unter der Bezeichnung ‚Attentive Variational Information Bottleneck’ (AVIB) entwickelt, das die Entwicklung therapeutischer Impfstoffe gegen Krebs…
HEIDELBERG, Alemania, 27 de julio de 2023 /PRNewswire/ — NEC Laboratories Europe y NEC Laboratories America han desarrollado un nuevo modelo de inteligencia artificial denominado Attentive Variational Information Bottleneck (AVIB), que supone un avance en el desarrollo de vacunas…